SONN logo

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Profile

Full Name

Sonnet BioTherapeutics Holdings, Inc.

Ticker

NASDAQ: SONN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 31, 2006

Indexes

Not included

Website

https://www.sonnetbio.com

Employees

13

Key Details

Price

$1.26

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$18.60K(-87.42% YoY)

Annual EPS

-$11.35(92.18% YoY)

PE Ratio

-

Next earnings date

Dec 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.26
    SONN price is $1.26

    30-Day Relative Volume

    9.80
    SONN 30-day relative volume is 9.80

    Price Performance

    Price Most Recent Change

    -
    SONN price change on Dec 2, 2025 is unknown

    Price YTD Change

    -13.7%
    SONN price is down -13.7% since January 1st

    Price 1-Year Change

    -26.74%
    SONN price is down -26.74% year-on-year

    Price 3-Year Change

    -99.25%
    SONN price is down -99.25% over the past 3 years

    Price Range

    Price All-Time High

    $8008000.00
    SONN price is currently -100.00% below its historical high of $8008000.00

    Price 3-Year Low

    $1.08
    SONN price is currently +16.67% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $7.89M
    SONN market cap is $7.89 million

    Market Cap 3-Year Change

    +3.58%
    SONN market cap is up +3.58% over the past 3 years

    Market Cap All-Time High

    $1078.28B
    SONN market cap is currently -100.00% below its historical high of $1078.28 billion

    Market Cap Sector Percentile

    15.05%
    SONN market cap is higher than 15.05% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +132.83%
    SONN shares outstanding is up +132.83% year-on-year

    Shares Outstanding 3-Year Change

    +13789.58%
    SONN shares outstanding is up +13789.58% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.09
    SONN beta is 1.09

    200-day SMA

    $3.01
    SONN price is currently -58.17% below its 200-day simple moving average

    50-day SMA

    $4.62
    SONN price is currently -72.71% below its 50-day simple moving average

    14-Day RSI

    28.15
    SONN 14-day relative strength index is 28.15

    Volume

    9.80
    SONN 30-day relative volume is 9.80

    ATR

    $0.88
    SONN average true range is $0.88

    10-day Historical Volatility

    294.73%
    SONN 10-day historical volatility is 294.73%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $18.60K
    SONN annual revenue is $18.60 thousand

    Revenue Analysts Estimate

    $1.00M
    SONN annual revenue is currently -98.14% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -87.42%
    SONN annual revenue is down -87.42% year-on-year

    Revenue Sector Percentile

    29.42%
    SONN annual revenue is higher than 29.42% of companies in Healthcare sector

    EPS

    EPS

    -$11.35
    SONN annual earnings per share is -$11.35

    EPS Analysts Estimate

    -$3.46
    SONN annual earnings per share is currently -228.05% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +92.18%
    SONN annual earnings per share is up +92.18% year-on-year

    EPS Sector Percentile

    13.9%
    SONN annual earnings per share is higher than 13.9% of companies in Healthcare sector

    Profit

    Gross Profit

    -$64.50K
    SONN annual gross profit is -$64.50 thousand

    Gross Margin

    -346.77%
    SONN annual gross profit margin is -346.77%

    Operating Profit

    -$11.84M
    SONN annual operating income is -$11.84 million

    Operating Margin

    -63.64K%
    SONN annual operating profit margin is -63.64 thousand%

    Net Income

    -$7.44M
    SONN annual net profit is -$7.44 million

    Net Margin

    -39.98K%
    SONN annual net profit margin is -39.98 thousand%

    Expenses

    Total Expenses

    $7.46M
    SONN annual total expenses is $7.46 million

    Operating Expenses

    $11.77M
    SONN annual total operating expenses is $11.77 million

    Cost Of Goods Sold

    $83.10K
    SONN annual cost of goods sold is $83.10 thousand

    Selling, General & Administrative Expenses

    $0.00
    SONN annual SG&A is $0.00

    Depreciation & Amortization

    $83.10K
    SONN annual D&A is $83.10 thousand

    Interest Expense

    $0.00
    SONN annual interest expense is $0.00

    Income Tax

    $0.00
    SONN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$11.84M
    SONN annual earnings before interest & taxes is -$11.84 million

    EBITDA

    -$11.75M
    SONN annual EBITDA is -$11.75 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $2.77M
    SONN annual total assets is $2.77 million

    Non Current Assets

    $653.10K
    SONN annual long term assets is $653.10 thousand

    Current Assets

    $2.12M
    SONN annual total current assets is $2.12 million

    Cash and Cash Equivalents

    $149.50K
    SONN annual cash & cash equivalents is $149.50 thousand

    Accounts Receivable

    -
    SONN annual accounts receivable value is unknown

    Inventory

    $0.00
    SONN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $3.26M
    SONN annual total liabilities is $3.26 million

    Long Term Liabilities

    $46.60K
    SONN annual total long term liabilities is $46.60 thousand

    Current Liabilities

    $3.21M
    SONN annual current liabilities is $3.21 million

    Accounts Payable

    $2.18M
    SONN annual accounts payable is $2.18 million

    Debt

    Total Debt

    $130.90K
    SONN annual total debt is $130.90 thousand

    Total Debt 1-Year Change

    -35.8%
    SONN annual total debt is down -35.8% year-on-year

    Long Term Debt

    $46.60K
    SONN annual long term debt is $46.60 thousand

    Short Term Debt

    $84.30K
    SONN annual short term debt is $84.30 thousand

    Equity & Capital

    Shareholders Equity

    -$485.70K
    SONN annual stockholders equity is -$485.70 thousand

    Book Value

    -$485.70K
    SONN annual book value is -$485.70 thousand

    Retained Earnings

    -$117.68M
    SONN annual retained earnings is -$117.68 million

    Working Capital

    -$1.09M
    SONN annual working capital is -$1.09 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$8.61M
    SONN annual cash from operations is -$8.61 million

    Cash From Operations 1-Year Change

    +59.67%
    SONN annual cash from operations is up +59.67% year-on-year

    Cash From Investing

    -$12.00K
    SONN annual cash from investing is -$12.00 thousand

    Cash From Investing 1-Year Change

    +97.29%
    SONN annual cash from investing is up +97.29% year-on-year

    Cash From Financing

    $6.49M
    SONN annual cash from financing is $6.49 million

    Cash From Financing 1-Year Change

    -69.08%
    SONN annual cash from financing is down -69.08% year-on-year

    CAPEX

    CAPEX

    $12.00K
    SONN annual capital expenditures is $12.00 thousand

    CAPEX 1-Year Change

    -97.29%
    SONN annual capital expenditures is down -97.29% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$8.62M
    SONN annual free cash flow is -$8.62 million

    Free Cash Flow 1-Year Change

    +60.43%
    SONN annual free cash flow is up +60.43% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -346.77%
    SONN annual gross profit margin is -346.77%

    Operating Margin

    -63.64K%
    SONN annual operating profit margin is -63.64 thousand%

    Net Margin

    -39.98K%
    SONN annual net profit margin is -39.98 thousand%

    ROA & ROE

    ROA

    -181.38%
    SONN annual return on assets is -181.38%

    ROE

    1531.23%
    SONN annual return on equity is 1531.23%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    SONN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    SONN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -2.59
    SONN price to book ratio is -2.59

    PB Ratio Sector Percentile

    8.12%
    SONN price to book ratio is higher than 8.12% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    7.89
    SONN price to sales ratio is 7.89

    PS Ratio Sector Percentile

    66.71%
    SONN price to sales ratio is higher than 66.71% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $7.64M
    SONN enterprise value is $7.64 million

    Enterprise Value Sector Percentile

    19.78%
    SONN enterprise value is higher than 19.78% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.55
    SONN EV/EBITDA is -0.55

    EV/EBITDA Sector Percentile

    52.45%
    SONN EV/EBITDA is higher than 52.45% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    0.66
    SONN annual current ratio is 0.66

    Quick Ratio

    0.66
    SONN annual quick ratio is 0.66

    Leverage

    Debt To Equity

    -0.27
    SONN annual debt to equity ratio is -0.27

    Interest Coverage Ratio

    -
    SONN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    SONN piotroski f-score value is unknown

    Altman Z-Score

    -72.57
    SONN altman z-score is -72.57

    Analyst ratings

    Recent major analysts updates

    Apr 7, 25 Chardan Capital
    Buy
    Mar 28, 25 Chardan Capital
    Buy
    Dec 20, 24 Chardan Capital
    Buy
    Aug 23, 24 Chardan Capital
    Buy
    May 28, 24 Chardan Capital
    Buy
    May 16, 24 EF Hutton
    Buy
    Feb 15, 24 Chardan Capital
    Buy
    Nov 27, 23 Ladenburg Thalmann
    Buy
    Aug 16, 23 Chardan Capital
    Buy
    Jun 26, 23 EF Hutton
    Buy

    Institutional Ownership

    Screeners with SONN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Earnings today
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Sonnet BioTherapeutics Holdings, Inc.?
    • Does Sonnet BioTherapeutics Holdings, Inc. pay dividends?
    • What sector is Sonnet BioTherapeutics Holdings, Inc. in?
    • What industry is Sonnet BioTherapeutics Holdings, Inc. in?
    • What country is Sonnet BioTherapeutics Holdings, Inc. based in?
    • When did Sonnet BioTherapeutics Holdings, Inc. go public?
    • Is Sonnet BioTherapeutics Holdings, Inc. in the S&P 500?
    • Is Sonnet BioTherapeutics Holdings, Inc. in the NASDAQ 100?
    • Is Sonnet BioTherapeutics Holdings, Inc. in the Dow Jones?
    • When was Sonnet BioTherapeutics Holdings, Inc.'s last earnings report?
    • When does Sonnet BioTherapeutics Holdings, Inc. report earnings?

    What is the ticker symbol for Sonnet BioTherapeutics Holdings, Inc.?

    The ticker symbol for Sonnet BioTherapeutics Holdings, Inc. is NASDAQ:SONN

    Does Sonnet BioTherapeutics Holdings, Inc. pay dividends?

    No, Sonnet BioTherapeutics Holdings, Inc. does not pay dividends

    What sector is Sonnet BioTherapeutics Holdings, Inc. in?

    Sonnet BioTherapeutics Holdings, Inc. is in the Healthcare sector

    What industry is Sonnet BioTherapeutics Holdings, Inc. in?

    Sonnet BioTherapeutics Holdings, Inc. is in the Biotechnology industry

    What country is Sonnet BioTherapeutics Holdings, Inc. based in?

    Sonnet BioTherapeutics Holdings, Inc. is headquartered in United States

    When did Sonnet BioTherapeutics Holdings, Inc. go public?

    Sonnet BioTherapeutics Holdings, Inc.'s initial public offering (IPO) was on October 31, 2006

    Is Sonnet BioTherapeutics Holdings, Inc. in the S&P 500?

    No, Sonnet BioTherapeutics Holdings, Inc. is not included in the S&P 500 index

    Is Sonnet BioTherapeutics Holdings, Inc. in the NASDAQ 100?

    No, Sonnet BioTherapeutics Holdings, Inc. is not included in the NASDAQ 100 index

    Is Sonnet BioTherapeutics Holdings, Inc. in the Dow Jones?

    No, Sonnet BioTherapeutics Holdings, Inc. is not included in the Dow Jones index

    When was Sonnet BioTherapeutics Holdings, Inc.'s last earnings report?

    Sonnet BioTherapeutics Holdings, Inc.'s most recent earnings report was on August 13, 2025

    When does Sonnet BioTherapeutics Holdings, Inc. report earnings?

    The next expected earnings date for Sonnet BioTherapeutics Holdings, Inc. is December 17, 2025
    On this page